CD69 and viral infectious disease: Available evidence suggests that RBAC is a potent inducer of NKC cytotoxicity against aberrant cells due to viral infection and tumorigenesis [58,63,64,65,66,67,68], achieved through increased CD69 and CD25 surface markers [58,64].